Product Information
MELOXICAM 10 MG CAPSULE is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $11.1425 per EA under NDC 70954007710. Its NADAC has been published 127 times since Mar 20, 2024.
FDA first approved this application on Mar 9, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Meloxicam market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
70954007710
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
MELOXICAMApproval Type
Generic (ANDA)
FDA Application
ANDA211398FDA Approved
3/9/2021
TE Code
AB
On Market Since
3/10/2021
Pharmacological Classes
Price Statistics
The NADAC for MELOXICAM 10 MG CAPSULE has been published 127 times since Mar 20, 2024, and over the history we have for it it has declined 30.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.1425 per EA |
|---|---|
| All-time high | $15.9668 (Apr 10, 2024) |
| All-time low | $9.3007 (Oct 22, 2025) |
| 52-week high | $11.1425 |
| 52-week low | $9.3007 |
| Median price | $10.6798 |
| Average price | $10.9708 |
| Largest weekly change | -17.1% (Apr 17, 2024) |
| Weeks tracked | 127 |
| Tracking since | Mar 20, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MELOXICAM 10 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for MELOXICAM 10 MG CAPSULE, manufactured by ANI Pharmaceuticals, Inc., is $11.1425 per EA (NDC 70954007710), effective Aug 19, 2026.
How has the price of MELOXICAM 10 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for MELOXICAM 10 MG CAPSULE has declined 30.2%. It has been tracked across 127 weekly CMS publications since Mar 20, 2024.
What are the highest and lowest recorded NADAC prices for MELOXICAM 10 MG CAPSULE?
Since Mar 20, 2024, the NADAC for MELOXICAM 10 MG CAPSULE has ranged from a low of $9.3007 (Oct 22, 2025) to a high of $15.9668 (Apr 10, 2024), with a median of $10.6798 per EA.
Are there cheaper alternatives to MELOXICAM 10 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as MELOXICAM 10 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures MELOXICAM 10 MG CAPSULE?
MELOXICAM 10 MG CAPSULE (NDC 70954007710) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.